Análise sociodemográfica e clínica de pessoas vivendo com HIV em abandono da terapia antirretroviral e que evoluíram para o óbito

Abstract

The HIV and Aids represents a challenge to the public health, as it reached in the world more than 70 million people and of this amount, 25 million people were killed by its consequences. The antiretroviral therapy is essential to the viral suppression and low transmissibility of HIV. However, the abandonment of the treatment is a factor for predisposition to opportunistic infections and death due to AIDS. In this perspective, it was aimed to analyze the sociodemographic and clinical characteristics of people that live with HIV, abandoned the antiretroviral therapy and evolved to the death in a specialized assistance service. Documentary and analytic study with a quantitative approach, conducted from October of 2017 to March of 2018, through the use of medical records from a specialized assistance service in Campina Grande/PB. The sample was of 170 medical records about abandonments and 26 medical records about death. Two tests were performed: Qui -square and Fisher, being associated with the variables with a value of p <0.05 with a level of signifi cance of 95%. It was possible to verify association among male sex with CD4 + ≥200 cells / mm³, aged <38 (p = 0.028); age <38 and> 10,000 copies / ml viral load at the start of antiretroviral therapy (p = 0.014); age ≥38 and <50 copies / ml viral load at the last visit (p = 0.005), schooling> 9 years and ≤10,000 copies / ml viral load at the start of antiretroviral therapy (p = 0.044); as well as schooling> 9 years and <50 copies / ml viral load at the last visit (p = 0.004); (p = 0.004), male sex and time of antiretroviral therapy ≤48 months (p = 0.011), age <38 and time of antiretroviral therapy ≤48 months (p = 0.003). It is concluded that the importance of this study based on the sociodemographic and clinical characteristics of PVHIV that abandoned the TARV and patients who died in a SAE enables to identify the relevance in the findings, making necessary an intensification of evaluation with a view of the evidenced characteristics of PVHIV that left the TARV, with a view aimed to the continuity of the treatment in order to improve the clinical situation.